The United States Food and Drugs Administration (USFDA) has conducted an inspection at Unit-1 of Shilpa Pharma Lifesciences Limited, a wholly owned subsidiary of Shilpa Medicare Limited located at Raichur from March 3-7, 2025. On conclusion of inspection, we received 1 (one) observation in form 483, which is procedural in nature.
The company will closely work with the agency and remain committed to address this observation comprehensively within stipulated time.
Shares of Shilpa Medicare Limited was last trading in BSE at Rs. 660.85 as compared to the previous close of Rs. 641.05. The total number of shares traded during the day was 5264 in over 493 trades.
The stock hit an intraday high of Rs. 675.15 and intraday low of 648.00. The net turnover during the day was Rs. 3504562.00. |
